Bunkyo, Japan

Ikuo Hayashi

This inventor holds 2 USPTO granted patents. Top assignees: Perseus Proteomics Inc., The University of Tokyo. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ikuo Hayashi. Retrieved from https://idiyas.com/inventor/ikuo-hayashi-mg9q6a5c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ikuo Hayashi: Innovator in Therapeutic Agents

Introduction

Ikuo Hayashi is a prominent inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of Alzheimer's disease and cancer. With a total of two patents to his name, Hayashi's work is focused on developing innovative solutions for critical health challenges.

Latest Patents

Hayashi's latest patents revolve around therapeutic agents for Alzheimer's disease and cancer. His research aims to provide a therapeutic drug that contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative. This innovative approach seeks to address the pressing need for effective treatments for these debilitating conditions.

Career Highlights

Throughout his career, Ikuo Hayashi has been associated with esteemed institutions such as the University of Tokyo and Perseus Proteomics Inc. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Hayashi has collaborated with notable colleagues, including Takeshi Iwatsubo and Tatsuhiko Kodama. These partnerships have further enriched his research endeavors and have played a crucial role in his innovative projects.

Conclusion

Ikuo Hayashi's contributions to the development of therapeutic agents for Alzheimer's disease and cancer highlight his dedication to addressing significant health issues. His innovative work continues to inspire advancements in medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…